Delivery Order SPE2DB24D2013-SPE2DB25FCKCE
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets in a quantity of 100 units. This is a firm fixed-price delivery order valued at $10,073.70 with an ultimate completion date of August 15, 2025. The contract is not set-aside and was competitively awarded. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, the corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $1,117.35 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100mg tablets (100 count) with an ultimate completion date of August 25, 2025. This firm fixed price, non-set-aside contract was awarded on August 22, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The antimalarial medication will support federal medical supply requirements, likely for military personnel...
- The Defense Logistics Agency awarded a delivery order valued at $3,469.83 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Atovaquone-Proguanil 250-100mg in 100-count units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 8, 2025, performed at the contractor's facility in Conshohocken, Pennsylvania. The antimalarial medication delivery supports federal medical procurement requirements, particularly for military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100-count units) with a ceiling value of $6,804.82. This is a firm fixed-price delivery order under a competitive, non-set-aside procurement. The order has an ultimate completion date of September 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,357.43 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 (100 tablets), a antimalarial pharmaceutical commonly used for malaria prevention and treatment in military personnel. The contract was executed on July 14, 2025, with an ultimate completion date of July 15, 2025, and represents a firm fixed-price, non-set-aside competitive award. Performance will be fulfilled from the contractor's location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count) with a contract value of $5,372.64. The award, issued on July 24, 2025, represents a firm fixed-price delivery order with an ultimate completion date of July 25, 2025. This non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Atovaquone-Proguanil is an antimalarial...
- The Defense Logistics Agency awarded a delivery order valued at $10,096.69 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 100 tablets, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Atovaquone-Proguanil is an antimalarial medication commonly used for malaria prophylaxis and treatment in military...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,245.97 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 (100 tablets), a antimalarial medication used primarily for malaria prophylaxis and treatment in military personnel. The contract was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, under firm fixed price terms with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $4,963.64 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100mg tablets (100 count) on September 9, 2025, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The pharmaceutical product is an antimalarial medication commonly used for malaria prevention and...
- The Defense Logistics Agency awarded a delivery order valued at $2,217.11 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 (100 tablets), with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Atovaquone-Proguanil is an antimalarial medication commonly prescribed for malaria prophylaxis and treatment,...
- SPE2DB24D2013Indefinite Delivery Contract
- SPE2DB24D2013-SPE2DB25FCKCEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count) with a firm fixed price ceiling value of $6,788.82. This contract, which is not set-aside and represents a competitive award, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. The delivery order utilizes AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for the U.S. military healthcare system. Atovaquone-Proguanil is an antimalarial medication commonly used for malaria prophylaxis and treatment within military medical supply chains. AmerisourceBergen Drug Corp, as a major pharmaceutical distributor and critical federal vendor, maintains broad capability to fulfill diverse medical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contracts demonstrates consistent competitively awarded delivery orders across therapeutic domains, positioning it as a reliable supplier for the Defense Logistics Agency's medical supply operations supporting military personnel and veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 9/4/25 |